Pintas & Mullins Law Firm

Blog Posts in April, 2016

  • Xarelto Approved for Extended Patent Protection

    More than 4,500 plaintiffs have filed lawsuits against Xarelto’s manufacturer over the drug’s side effects, including uncontrollable bleeding and death. Despite these mounting lawsuits, U.S. officials just approved the drug for extended patent protection, so Xarelto will only be available under brand name until 2024. Our team of Xarelto lawyers examines this patent extension and how it affects our ...
    Continue Reading
  • Celebrating Earth Day

    This Earth Day, our toxic substance attorneys want to highlight the importance of environmental contamination law. Whether we realize it or not, we encounter chemicals and naturally occurring toxins every single day. Chemicals There are currently more than 80,000 chemicals available for use in the U.S. Our mesothelioma lawyers recently posted a blog about how toxic substances are approved for ...
    Continue Reading
  • How New York's Medical Malpractice Insurance Changes Can Affect Injured Patients

    Our team of medical malpractice lawyers represent injured clients in New York, where the malpractice insurance market is undergoing significant change. Although this may not be on the public’s radar, it could leave injured patients vulnerable and without prompt payments. When a patient is seriously injured or killed from medical negligence, the have the right to file a claim against the doctor, ...
    Continue Reading
  • How Lawyers Defend Asbestos Companies

    It is our mission as lung cancer and mesothelioma lawyers to make sure our clients understand the legal process. Asbestos litigation is complex, but we take great pride in how comfortable our clients are asking questions about any topic related to their case. In this post, we want to shed light on an issue that is rarely discussed but is extremely important in understanding lung cancer, ...
    Continue Reading
  • New Device for Morcellator Surgeries Approved but Not Proven

    On Thursday, April 7, 2016, the FDA allowed a new device onto market that claims to contain tissue during power morcellator procedures. The device, PneumoLiner, is not proven to reduce the risk of spreading cancer. The uterine cancer lawyers at Pintas & Mullins Law Firm shed light on this new device and its risks below. Morcellator Background Power morcellators were commonly used during ...
    Continue Reading
  • Women Bring Taxotere Permanent Hair Loss Claims to Court

    Taxotere, a popular chemotherapy treatment for breast cancer, is causing permanent hair loss in thousands of women. As a wave of litigation hits the drug’s manufacturer, our team of Taxotere lawyers details how this drug evaded FDA and public scrutiny for so long. Temporary hair loss from chemotherapy treatments is well known and accepted. Like other chemotherapies, Taxotere is given through ...
    Continue Reading
Page 1 of 1